Insulin aspart, recombinant Subcutaneous and Ipratropium Bromide
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ipratropium Bromide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ipratropium Bromide eent
- Insulin aspart, recombinant Subcutaneous-Ipratropium Bromide Nebuamp
- Insulin aspart, recombinant Subcutaneous-Ipratropium inhalation
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation Aerosol
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation Solution
- Insulin aspart, recombinant Subcutaneous-Ipratropium Inhalation, oral/nebulization
- Ipratropium Bromide-Insulin degludec
- Ipratropium Bromide-Insulin Degludec (U-100) Prefilled Pens
- Ipratropium Bromide-Insulin Degludec (U-100) Vials
- Ipratropium Bromide-Insulin Degludec (U-200) Prefilled Pens
- Ipratropium Bromide-Insulin degludec and liraglutide
- Ipratropium Bromide-Insulin degludec and liraglutide Subcutaneous